Selenium causes growth inhibition and apoptosis in human brain tumor cell lines

N Sundaram1, A K Pahwa, M D Ard

  • 1Department of Neurosurgery, University of Mississippi Medical Center, Jackson 39216-4505, USA.

Insights

Selenium inhibits human glioma cell growth and damages mitochondria, inducing apoptosis. However, high-passage fibroblasts show resistance, suggesting acquired tolerance to selenium toxicity.

Area of Science:

  • Cell Biology
  • Toxicology
  • Oncology

Background:

  • Trace elements like selenium play crucial roles in cellular processes.
  • Understanding selenium's impact on cancer cells versus normal cells is vital for therapeutic development.
  • Glioma cell lines and fibroblasts serve as models to study cellular responses to xenobiotics.

Purpose of the Study:

  • To investigate the effects of selenium on human glioma cell lines and dermal fibroblasts.
  • To assess selenium's impact on cell growth, mitochondrial function, and apoptosis.
  • To determine if cell passage number influences sensitivity to selenium.

Main Methods:

  • Cell cultures of T98G, U373MG, and U87MG glioma lines, plus dermal fibroblasts.
  • Treatment with sodium selenite.
  • Assays for cell viability, mitochondrial function (MTT assay), and apoptosis (electron microscopy).

Main Results:

  • Selenium significantly inhibited glioma cell growth and induced mitochondrial damage and apoptosis.
  • Minimally passaged fibroblasts showed sensitivity, while high-passage fibroblasts exhibited resistance.
  • Ultrastructural analysis revealed electron-dense inclusions in mitochondria post-selenium treatment.

Conclusions:

  • Selenium exhibits potent anti-cancer effects against glioma cells by impairing mitochondrial function and inducing apoptosis.
  • Cellular resistance to selenium can develop with repeated passaging, particularly in fibroblasts.
  • These findings highlight selenium's differential effects based on cell type and passage history, with implications for its therapeutic use.

Related Concept Videos